MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Nicola Flaum; Emma J. Crosbie; Emma Roisin Woodward; Fiona Lalloo; Robert Morgan; Neil Ryan; D. Gareth Evans

Journal ArticleOPEN ACCESS

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Flaum N
Crosbie E
Woodward E
et al.

Journal of Medical Genetics (2023) 60(6) 576-577

DOI: 10.1136/jmg-2022-109055

1Citations

3Readers

Author supplied keywords

Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic Counselling
Genetic Predisposition to Disease
Genetic Testing
gynaecology

Cite

CITATION STYLE

APA

Flaum, N., Crosbie, E. J., Woodward, E. R., Lalloo, F., Morgan, R., Ryan, N., & Evans, D. G. (2023). MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1. Journal of Medical Genetics, 60(6), 576–577. https://doi.org/10.1136/jmg-2022-109055

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Author supplied keywords

Cite

Register to see more suggestions